Molecular Cytogenetics - Global Strategic Business Report

Report
657 Pages
March 2024
Region: Global
Global Industry Analysts, Inc
ID: 1882083

The global market for Molecular Cytogenetics is estimated at US$2 Billion in 2023 and is projected to reach US$3.5 Billion by 2030, growing at a CAGR of 7.6% from 2023 to 2030. This comprehensive report provides an in-depth analysis of market trends, drivers, and forecasts, helping you make informed business decisions.

Key Insights:

Market Growth: Understand the significant growth trajectory of the Molecular Cytogenetics Consumables segment, which is expected to reach US$2 Billion by 2030 with a CAGR of 7.7%. The Instruments segment is also set to grow at 6.8% CAGR over the next 8 years.
Regional Analysis: Gain insights into the U.S. market, estimated at $859.4 Million in 2023, and China, forecasted to grow at an impressive 8.8% CAGR to reach $231.4 Million by 2030. Discover growth trends in other key regions, including Japan, Canada, Germany, and the Asia-Pacific.

Why You Should Buy This Report:

Detailed Market Analysis: Access a thorough analysis of the Global Molecular Cytogenetics Market, covering all major geographic regions and market segments.
Competitive Insights: Get an overview of the competitive landscape, including the market presence of major players across different geographies.
Future Trends and Drivers: Understand the key trends and drivers shaping the future of the Global Molecular Cytogenetics Market.
Actionable Insights: Benefit from actionable insights that can help you identify new revenue opportunities and make strategic business decisions.

Key Questions Answered:

How is the Global Molecular Cytogenetics Market expected to evolve by 2030?
What are the main drivers and restraints affecting the market?
Which market segments will grow the most over the forecast period?
How will market shares for different regions and segments change by 2030?
Who are the leading players in the market, and what are their prospects?

Report Features:

Comprehensive Market Data: Independent analysis of annual sales and market forecasts in US$ Million from 2023 to 2030.
In-Depth Regional Analysis: Detailed insights into key markets, including the U.S., China, Japan, Canada, Europe, Asia-Pacific, Latin America, Middle East, and Africa.
Company Profiles: Coverage of major players such as Abbott Laboratories, Inc., Agilent Technologies, Inc., Bio-Rad Laboratories, Inc., and more.
Complimentary Updates: Receive free report updates for one year to keep you informed of the latest market developments.

Select Competitors (Total 44 Featured):

Abbott Laboratories, Inc.
Agilent Technologies, Inc.
Bio-Rad Laboratories, Inc.
Illumina, Inc.
Abbott Molecular, Inc.
F. Hoffmann-La Roche AG
CytoSport, Inc.
Esperite NV
Eurofins Scientific SE
GeneDx
Empire Genomics LLC
BioDiscovery, Inc.
FUJIFILM Irvine Scientific
ADS Biotec, Inc.
BIOVIEW Ltd.

MarketGlass Platform

Our reports are enhanced by the MarketGlass platform, which brings together industry experts and influencers to provide high-quality, accurate insights. This unique platform allows us to gather comprehensive data and market perspectives, ensuring you receive the most reliable and detailed analysis available.

I. METHODOLOGYII. EXECUTIVE SUMMARY

1. MARKET OVERVIEW

Molecular Cytogenetics Technologies: An Introductory Prelude
Future Prospects Remain Favorable for Cytogenetics Technologies
Uptrend in Life Sciences R&D and Healthcare Spending Creates Fertile Environment
World Healthcare Expenditure (In US$ Billion) for the Years 2017-2023
Healthcare Costs as a % of GDP by Country for the Years 2020 & 2023
Northbound Trajectory in Med Tech Sector to Generate Parallel Opportunities
Developed Regions: Key Revenue Contributors
Developed Regions Account for Lion's Share of World Molecular Cytogenetics Technologies Market: Percentage Breakdown of Revenues for Developed and Developing Regions (2023 & 2030)
Fast Paced Growth Projected in Developing Regions
Global Market for Molecular Cytogenetics Technologies - Geographic Regions Ranked by % CAGR (Revenues) for 2023 & 2030: China, Asia-Pacific, Latin America, USA, Middle East, Africa, Canada, Europe, and Japan
Competitive Scenario
Recent Market Activity
Molecular Cytogenetics - Global Key Competitors Percentage Market Share in 2023 (E)
Competitive Market Presence - Strong/Active/Niche/Trivial for Players Worldwide in 2023 (E)

2. FOCUS ON SELECT PLAYERS

3. MARKET TRENDS & DRIVERS

Critical Importance of Molecular Biology in Laboratory Processes: Cornerstone for Present & Future Growth
Advanced Molecular Biology Techniques Broaden the Scope of Cytogenetics Technologies
Comparative Genome Hybridization (CGH): Largest & Fastest Growing Market Segment
Rising Adoption of Array Based CGH to Spur Overall Demand
Array-based Technologies Continue to Cannibalize Sales from FISH Technology: Percentage (%) Share of Array-Based Solutions in World Cytogenetics Technologies Market (2018 & 2023)
aCGH Simplifies Diagnosis of Chromosomal Anomalies
Clinical Pathological Testing: A Growing Vertical for aCGH
Impact of Rising Emphasis on R&D on Microarray Technology
Leveraging Established Use Case, FISH Technology Continues to Find Favor
Next Generation Sequencing Seeks Role in Cytogenetics Processes
Molecular Cytogenetics Greatly Benefit Cancer Prognosis
Breakdown of Total Number of Cancer Cases by Region: 2023
Breakdown of Total Number of Cancer Cases by Type: 2023
Global Cancer Incidence: Number of New Cancer Cases in Million for the Years 2018, 2020, 2025, 2030, 2035 and 2040
Cancer Care Made Easier with Highly-Multiplexed FISH
Diverse Applications of FISH Technology in Oncology
Growing Demand for Targeted Therapies in Cancer Treatment Presents Lucrative Opportunities
Increasing Significance of Cytogenetic Analysis in Genetic Disease Diagnosis
Uptrend in Genetic Disease Testing Augments Prospects
List of Genetic Disorders by Event, Genetic Manifestation and Prevalence
Top Ten Genetic Diseases Worldwide
Proven Efficacy in Nucleic Acid Diagnostics Favors Market Growth
Expanding Role of Molecular Cytogenetics in Personalized Medicine
Global Personalized Medicine Market: Revenues in US$ Million for the Years 2019, 2021, 2023 and 2025
World Personalized Medicine Market by Region/Country (2023): Percentage Breakdown of Revenues for US, Canada, Japan, Europe, Asia-Pacific and Rest of World
Drug Ineffectiveness for Select Therapeutic Categories as a Percentage of Patient Population
Companion Diagnostics Lead the Way to Personalized Medicine
Digitalization, Automation and AI Trends Set to Shape Future Growth
Lab Automation Speeds Up
World Laboratory Automation Market in US$ Billion for Years 2018, 2020, 2022, 2024 & 2026
Laboratory 4.0 Set to Transform Molecular Cytogenetics Landscape
Laboratory Information Systems Gain Traction
Artificial Intelligence : The Future of LIS
Biotech Research Spending Patterns Steer Momentum
Technology Advancements & Improvements Bolster Growth
Ageing Demographics to Drive Demand
Global Aging Population Statistics for the 65+ Age Group in Million by Geographic Region for the Years 2019, 2025, 2035 and 2050
Elderly Population (65+ Years) as a % of Total Population by Developed, Less Developed and Least Developed Regions: 2019 & 2030
Life Expectancy at Age 60 and 80 Years: (2010-2015), (2020-2025) & (2045-2050)
Technology Overview
A Preface to Cytogenetics
Basic Terms and Definitions in Molecular Biology
An Overview of Select Chromosomal Anomalies
Molecular Cytogenetics
Insight into Molecular Cytogenetics Techniques
Fluorescence in situ Hybridization (FISH)
Comparative Genomic Hybridization (CGH)
Advent of Microarray Technology
Microarrays in Comparative Genomic Hybridization
Principle Underlying aCGH
Low Resolution and High Resolution aCGH
A Review of Molecular Biology Techniques in Cytogenetics

4. GLOBAL MARKET PERSPECTIVE

Table 1: World Recent Past, Current & Future Analysis for Molecular Cytogenetics by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2023 through 2030 and % CAGR
Table 2: World Historic Review for Molecular Cytogenetics by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2014 through 2022 and % CAGR
Table 3: World 16-Year Perspective for Molecular Cytogenetics by Geographic Region - Percentage Breakdown of Value Revenues for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets for Years 2014, 2024 & 2030
Table 4: World Recent Past, Current & Future Analysis for Consumables by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2023 through 2030 and % CAGR
Table 5: World Historic Review for Consumables by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2014 through 2022 and % CAGR
Table 6: World 16-Year Perspective for Consumables by Geographic Region - Percentage Breakdown of Value Revenues for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2024 & 2030
Table 7: World Recent Past, Current & Future Analysis for Instruments by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2023 through 2030 and % CAGR
Table 8: World Historic Review for Instruments by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2014 through 2022 and % CAGR
Table 9: World 16-Year Perspective for Instruments by Geographic Region - Percentage Breakdown of Value Revenues for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2024 & 2030
Table 10: World Recent Past, Current & Future Analysis for Software & Services by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2023 through 2030 and % CAGR
Table 11: World Historic Review for Software & Services by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2014 through 2022 and % CAGR
Table 12: World 16-Year Perspective for Software & Services by Geographic Region - Percentage Breakdown of Value Revenues for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2024 & 2030
Table 13: World Recent Past, Current & Future Analysis for CGH by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2023 through 2030 and % CAGR
Table 14: World Historic Review for CGH by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2014 through 2022 and % CAGR
Table 15: World 16-Year Perspective for CGH by Geographic Region - Percentage Breakdown of Value Revenues for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2024 & 2030
Table 16: World Recent Past, Current & Future Analysis for FISH by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2023 through 2030 and % CAGR
Table 17: World Historic Review for FISH by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2014 through 2022 and % CAGR
Table 18: World 16-Year Perspective for FISH by Geographic Region - Percentage Breakdown of Value Revenues for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2024 & 2030
Table 19: World Recent Past, Current & Future Analysis for Immunohistochemistry by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2023 through 2030 and % CAGR
Table 20: World Historic Review for Immunohistochemistry by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2014 through 2022 and % CAGR
Table 21: World 16-Year Perspective for Immunohistochemistry by Geographic Region - Percentage Breakdown of Value Revenues for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2024 & 2030
Table 22: World Recent Past, Current & Future Analysis for Karyotyping by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2023 through 2030 and % CAGR
Table 23: World Historic Review for Karyotyping by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2014 through 2022 and % CAGR
Table 24: World 16-Year Perspective for Karyotyping by Geographic Region - Percentage Breakdown of Value Revenues for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2024 & 2030
Table 25: World Recent Past, Current & Future Analysis for Other Techniques by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2023 through 2030 and % CAGR
Table 26: World Historic Review for Other Techniques by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2014 through 2022 and % CAGR
Table 27: World 16-Year Perspective for Other Techniques by Geographic Region - Percentage Breakdown of Value Revenues for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2024 & 2030
Table 28: World Recent Past, Current & Future Analysis for Genetic Disorders by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2023 through 2030 and % CAGR
Table 29: World Historic Review for Genetic Disorders by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2014 through 2022 and % CAGR
Table 30: World 16-Year Perspective for Genetic Disorders by Geographic Region - Percentage Breakdown of Value Revenues for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2024 & 2030
Table 31: World Recent Past, Current & Future Analysis for Cancer by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2023 through 2030 and % CAGR
Table 32: World Historic Review for Cancer by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2014 through 2022 and % CAGR
Table 33: World 16-Year Perspective for Cancer by Geographic Region - Percentage Breakdown of Value Revenues for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2024 & 2030
Table 34: World Recent Past, Current & Future Analysis for Personalized Medicine by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2023 through 2030 and % CAGR
Table 35: World Historic Review for Personalized Medicine by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2014 through 2022 and % CAGR
Table 36: World 16-Year Perspective for Personalized Medicine by Geographic Region - Percentage Breakdown of Value Revenues for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2024 & 2030
Table 37: World Recent Past, Current & Future Analysis for Other Applications by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2023 through 2030 and % CAGR
Table 38: World Historic Review for Other Applications by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2014 through 2022 and % CAGR
Table 39: World 16-Year Perspective for Other Applications by Geographic Region - Percentage Breakdown of Value Revenues for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2024 & 2030
Table 40: World Recent Past, Current & Future Analysis for Clinical & Research Laboratories by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2023 through 2030 and % CAGR
Table 41: World Historic Review for Clinical & Research Laboratories by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2014 through 2022 and % CAGR
Table 42: World 16-Year Perspective for Clinical & Research Laboratories by Geographic Region - Percentage Breakdown of Value Revenues for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2024 & 2030
Table 43: World Recent Past, Current & Future Analysis for Pharma & Biotech Companies by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2023 through 2030 and % CAGR
Table 44: World Historic Review for Pharma & Biotech Companies by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2014 through 2022 and % CAGR
Table 45: World 16-Year Perspective for Pharma & Biotech Companies by Geographic Region - Percentage Breakdown of Value Revenues for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2024 & 2030
Table 46: World Recent Past, Current & Future Analysis for Academic Research Institutes by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2023 through 2030 and % CAGR
Table 47: World Historic Review for Academic Research Institutes by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2014 through 2022 and % CAGR
Table 48: World 16-Year Perspective for Academic Research Institutes by Geographic Region - Percentage Breakdown of Value Revenues for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2024 & 2030
Table 49: World Recent Past, Current & Future Analysis for Other End-Uses by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2023 through 2030 and % CAGR
Table 50: World Historic Review for Other End-Uses by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2014 through 2022 and % CAGR
Table 51: World 16-Year Perspective for Other End-Uses by Geographic Region - Percentage Breakdown of Value Revenues for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2024 & 2030
Table 52: World Molecular Cytogenetics Market Analysis of Annual Sales in US$ Thousand for Years 2014 through 2030

III. MARKET ANALYSIS

UNITED STATES

Molecular Cytogenetics Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United States for 2024 (E)
The United States: Prime Market for Cytogenetics Technologies
CGH Technologies Witness Higher Adoption
Established Role Sustains Momentum in FISH Technology
Ageing Population and Growing Incidence of Cancer & Lifestyle Diseases - Opportunity Indicators
US Elderly Population: Expected Growth Rates Over the Years 2005-2025
Leading Sites of New Cancer Cases in Males: 2023
Leading Sites of New Cancer Cases in Females: 2023
Emphasis on Personalized Medicine & Companion Diagnostics Widens Scope
US Personalized Medicine Market: Breakdown of Revenues (in US$ Billion) for 2014, 2018 and 2023
US Companion Diagnostics (CDx) Market: Breakdown of Revenues (in US$ Million) for 2014, 2018 and 2023
Growing Focus on Genetic Testing Widens the Business Case
Emphasis on Early Diagnosis & Need to Reduce Healthcare Costs Augment Demand

CANADA

An Overview
Rising Incidence of Chronic Diseases Spurs Genetic Testing Demand
Number of New Cancer Cases in Canada: 2023

JAPAN

Molecular Cytogenetics Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Japan for 2024 (E)
Japan Offers Robust Opportunities
Japanese Elderly (65+ Years) Population: 2000-2023
Breakdown of Population by Age Group in Japan: 2010, 2020, and 2025

CHINA

Molecular Cytogenetics Market Presence - Strong/Active/Niche/Trivial - Key Competitors in China for 2024 (E)
Market Overview

EUROPE

Molecular Cytogenetics Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Europe for 2024 (E)
A Mature yet Growing Market
Number of New Cancer Cases in Europe: 2012, 2018, and 2025

FRANCE

Molecular Cytogenetics Market Presence - Strong/Active/Niche/Trivial - Key Competitors in France for 2024 (E)

GERMANY

Molecular Cytogenetics Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Germany for 2024 (E)

ITALY

UNITED KINGDOM

Molecular Cytogenetics Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United Kingdom for 2024 (E)
Market Overview

SPAINRUSSIAREST OF EUROPE

ASIA-PACIFIC

Molecular Cytogenetics Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Asia-Pacific for 2024 (E)
Market Overview
Factors Driving Demand for Laboratory Technologies in Asia-Pacific

AUSTRALIA

Molecular Cytogenetics Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Australia for 2024 (E)

INDIA

Molecular Cytogenetics Market Presence - Strong/Active/Niche/Trivial - Key Competitors in India for 2024 (E)
Indian Microarray Market

SOUTH KOREAREST OF ASIA-PACIFIC

LATIN AMERICA

Molecular Cytogenetics Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Latin America for 2024 (E)

ARGENTINABRAZILMEXICOREST OF LATIN AMERICA

MIDDLE EAST

Molecular Cytogenetics Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Middle East for 2024 (E)

IRANISRAELSAUDI ARABIAUNITED ARAB EMIRATESREST OF MIDDLE EAST

AFRICA

Molecular Cytogenetics Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Africa for 2024 (E)

IV. COMPETITION

Companies Mentioned (Partial List)

A selection of companies mentioned in this report includes, but is not limited to:

Abbott Laboratories, Inc.
Agilent Technologies, Inc.
Bio-Rad Laboratories, Inc.
Illumina, Inc.
Abbott Molecular, Inc.
F. Hoffmann-La Roche AG
CytoSport, Inc.
Esperite NV
Eurofins Scientific SE
GeneDx
Empire Genomics LLC
BioDiscovery, Inc.
FUJIFILM Irvine Scientific
ADS Biotec, Inc.
BIOVIEW Ltd.

Table Information

Report Attribute	Details
No. of Pages	657
Published	March 2024
Forecast Period	2023 - 2030
Estimated Market Value ( USD ) in 2023	$ 2 Billion
Forecasted Market Value ( USD ) by 2030	$ 3.5 Billion
Compound Annual Growth Rate	8.3%
Regions Covered	Global

PURCHASE OPTIONS

Single User License PDF

1 - 10 User License PDF

Enterprise License PDF

need a quote ?

License	Format	Properties	Price
SINGLE USER LICENSE PDF	The product is a PDF.	This is a single user license, allowing one user access to the product.	€5382EUR$5,600USD£4,551GBP
1 - 10 USER LICENSE PDF	The product is a PDF.	This is a 1-10 user license, allowing up to ten users have access to the product.	€10226EUR$10,640USD£8,647GBP
ENTERPRISE LICENSE PDF	The product is a PDF.	This is an enterprise license, allowing all employees within your organization access to the product.	€16147EUR$16,800USD£13,654GBP

Key Insights:

Why You Should Buy This Report:

Key Questions Answered:

Report Features:

Select Competitors (Total 44 Featured):

MarketGlass Platform

Table of Contents

Companies Mentioned (Partial List)

Table Information

Related Topics

Related Reports

Global Molecular Cytogenetics Market by Product (Kits, Reagents, Probes, Instrument, Software, Services), Technique (FISH, CISH, Comparative Genomic Hybridization (Array-based, Standard)), Application (Cancer, Genetics Disorders) - Forecast to 2028

Molecular Cytogenetics Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2023-2028

Global Molecular Cytogenetics Market by Product (Consumables, Instruments, Software & Services), Technique (Comparative Genomic Hybridization, Fluorescence in Situ Hybridization), Application, End-User - Forecast 2024-2030

Molecular Cytogenetics Market Size, Share & Trends Analysis Report By Application (Oncology, Personalized Medicine), By Technology (FISH, Immunohistochemistry, Karyotyping), By Product, By End-use, By Region, And Segment Forecasts, 2023 - 2030

Molecular Cytogenetics Global Market Report 2024